In this paper, we demonstrate the design and fabrication of an AlGaN/GaN High Electron Mobility Transistor (HEMT) as a bio sensing platform. Bio-compatible functionalization process with thioglycolic acid and antibody-antigen immobilization process with EDC-NHS chemistry is optimized, and the AlGaN/GaN HEMT biosensor is validated using recombinant C3G (RAPGEF1) protein and an indigenously developed mouse monoclonal antibody (clone 3F6mAb). The designed biosensor with its extended source-drain pads and inter-digital gate sensing design increases sensitivity of device to detect low concentration of biological samples. C3G protein is detected by antigen-antibody conjugation over extended functionalized sensing gate area which resulted in 36.2% change in drain current output and the corresponding antigen is detected up to 500 pg/ml. The biosensor shows a resolution in mA range, which is easily implementable by circuit due to low noise factor. It can therefore be adopted for use to detect antigens in very small biological samples, required in diagnostic assays of bio-medical applications.
15 March 2021 in Semiconductor Science and Technology
This work reports on the development of a compact GaN high-electron-mobility transistor (HEMT) based biosensor for an easy and early detection of breast cancer biomarker C-erbB2 in the human cell line. The early-stage detection process includes a reaction of antibody-antigen through the cell line culture of a patient. The developed sensing chip has a two-finger gate structure of 125 µ m gate width, and a gate length of 5 µ m. In order to functionalize the gold surface of the fabricated sensor, the sensor chip has been immersed into an optimized 1 M aqueous solution of thioglycolic acid at room temperature for 15 h. Various characterization methods such as I–V, EDS, and FTIR confirm the formation of the Au–S complex. The functionalized sensors have been incubated in phosphate buffer saline solution of 200 µ g ml −1 C-erbB2 monoclonal antibody for 4 h. Thereafter, the C-erbB2 monoclonal antibody conjugated devices are incubated with human cancer cells positive for C-erbB2 on its cell surface. The biosensor shows a 31% change in drain current for an incubation period of 6 h. The high-resolution biosensing chip (in terms of high drain current levels of the order of mA) is unaffected by noise and eases the circuit for futuristic point of care diagnostics.
29 June 2022 in IEEE Transactions on Electron Devices
This work reports the development of a gallium nitride-based high electronic mobility transistor (GaN HEMT)-based biosensor to detect human epidermal growth factor receptor-2 (HER2) antigen in spiked human serum. The platform devices have been fabricated with a source to drain distance, gate length, and unit gate width of 25, 3, and $100 ~\mu \text{m}$ , respectively. The cysteine methyl ester (CME)-based chemistry has been utilized to immobilize the antiHER2 antibody on the sensing region of the sensor. The formation of the CME layer was confirmed through Raman spectroscopy, which shows a peak around a wavelength of 262 cm −1 . The antibody immobilization on the gold surface has been confirmed through enzyme-linked immunosorbent assay (ELISA). The sensor has been electrically characterized before and after each step of the functionalization process. The sensor shows a significant change in the drain current of 0.95 and 1.7 mA at a ${V}_{{\mathrm {ds}}} $ of +5 V for 50- and 200-ng/ml concentration of HER2 in spiked human serum. A minor change in the drain current of the sensor, when tested with a nonspecific antigen, suggested the high specificity of the sensor for HER2. The sensor has been tested for a broad range concentration of HER2 antigen from 0.7 pg/ml to 200 ng/ml.
1 December 2021 in Sensors and Actuators A: Physical
For the first time, a InAlGaN based HEMT has been used for biosensing applications. Also, machine learning techniques are introduced in the modelling of the physics of a semiconductor device.
This work reports rapid, label-free and specific detection of the HER2 antigen using a gallium nitride (GaN) high electron mobility transistor (HEMT). Thiol-based chemistry has been utilized to immobilize the corresponding HER2 antibody in the sensing area of the sensor. The formation of a gold–sulfur complex has been confirmed through Raman spectroscopy, giving a peak at around a wavelength of 260 cm−1. Fourier transform infrared spectroscopy and atomic force microscopy (AFM) also reveal the functionalization of thiol and free carboxylic groups. On-chip enzyme-linked immunosorbent assay has been utilized to confirm immobilization of antibody receptors on the sensing area surface, followed by current–voltage measurement. Morphology of the sensing area using AFM and electrical characterization of the sensor have been recorded before and after each functionalization process step. The sensor shows detection of the HER2 antigen in a broad range of 0.7 pg ml−1 to 10 μg ml−1i.e., (5 × 10−15 to 6 × 10−8 M). A long-time study and reusability aspect of the sensor have also been investigated that show good viability of the sensor. For the first time, a three-binding-site model based on the Langmuir isotherm has been developed for HER2 detection using GaN-HEMTs with three dissociation constants, i.e., 7 × 10−10, 8.8 × 10−11, and 7.2 × 10−9 M, respectively.